Clinical trial
Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or…
NCT00034177 · Achieve Life Sciences, Industry · Completed
Key facts
| NCT number | NCT00034177 |
|---|---|
| Title | Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the Urothelium |
| Official title | Safety And Efficacy Of Weekly Administration Of S-8184 Paclitaxel Injectable Emulsion In Second Line Treatment Of Patients With Locally Advanced, Metastatic, Or Recurrent Transitional Cell Carcinoma Of The Urothelium |
| Lead sponsor | Achieve Life Sciences, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Urologic Neoplasms |
| Intervention type | Drug |
| Interventions | S-8184 Paclitaxel Injectable Emulsion, Experimental Arm: TOCOSOL Paclitaxel |
| Enrollment | 27 |
| Start date | Apr 1, 2002 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Apr 25, 2002 |
| Last update posted | Jun 4, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: